Waystar Achieves Best in KLAS for Patient Access for Over a Decade
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 04 2026
0mins
Should l Buy WAY?
Source: PRnewswire
- Industry Recognition: Waystar has been named Best in KLAS for Patient Access, extending its streak of consecutive honors to over a decade, reflecting its outstanding performance in addressing healthcare financial challenges and solidifying its leadership in healthcare payment software.
- Financial Challenge Mitigation: Healthcare providers spend over $10 billion annually navigating complex payer authorization requirements, and Waystar's platform significantly reduces denial rates caused by front-end issues through real-time intelligence and autonomous workflows, enhancing client financial returns.
- Efficiency Gains: By integrating real-time visibility into insurance coverage with automated authorization, Waystar achieves a 55% reduction in eligibility-related denials and up to 90% auto-approval rates, thereby increasing provider revenue and improving patient access to care.
- Revenue Capture: Waystar aids providers in uncovering unknown insurance coverage before care begins, achieving a 55% discovery rate, and combined with pre-service estimation, accelerates collections and protects revenue, further enhancing patient satisfaction.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WAY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WAY
Wall Street analysts forecast WAY stock price to rise
17 Analyst Rating
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 25.880
Low
40.00
Averages
47.81
High
54.00
Current: 25.880
Low
40.00
Averages
47.81
High
54.00
About WAY
Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Enhanced AI Capabilities: Waystar's expanded collaboration with Google Cloud leverages Gemini large language models and cloud infrastructure to further enhance its AI-driven revenue cycle management capabilities, which is expected to accelerate innovation and improve market competitiveness.
- Data Integration Advantage: By capturing and normalizing rich financial and clinical data across a network of over one million healthcare providers, Waystar creates a self-learning revenue cycle that significantly improves efficiency in patient coverage identification and denial prevention.
- Significant Denial Prevention Outcomes: Since launching the industry's first generative AI capabilities for denial prevention and recovery in 2025, Waystar has successfully prevented over $15 billion in denied claims and reduced the time spent on denial appeals and recovery by 90%, greatly enhancing financial performance for healthcare providers.
- Future Outlook: Waystar's autonomous revenue cycle platform aims to minimize provider intervention needs through intelligent agents that continuously learn and operate in real-time, ensuring accuracy and transparency, thereby optimizing the entire healthcare payment ecosystem.
See More
- Enhanced AI Capabilities: Waystar's expanded collaboration with Google Cloud integrates its agentic AI capabilities directly into revenue cycle workflows, leveraging Gemini large language models and hyperscale infrastructure, which is expected to significantly improve revenue efficiency for healthcare providers.
- Significant Denial Prevention Outcomes: In less than a year, Waystar has successfully prevented over $15 billion in denied claims and reduced the time spent on denial appeals and recovery by 90%, which not only enhances client satisfaction but also strengthens the company's competitive position in the healthcare payment sector.
- Data-Driven Intelligent Decision Making: By integrating financial, clinical, and administrative data from over one million providers, Waystar has built one of the industry's largest proprietary datasets, enabling its AI platform to self-learn and optimize the revenue cycle, ensuring healthcare providers can eliminate friction in financial ecosystems in real-time.
- Future Outlook: Waystar's autonomous revenue cycle platform aims for a future of minimal intervention, allowing healthcare providers to leverage intelligent agents that continuously learn and optimize operations, thereby enhancing accuracy and transparency and further driving digital transformation in the healthcare industry.
See More

Partnership Announcement: Waystar has partnered with Google Cloud to enhance its capabilities in the autonomous revenue cycle management sector.
Focus on Innovation: The collaboration aims to leverage AI and cloud technology to accelerate advancements in revenue cycle processes.
See More
- Evercore Strong Performance: Evercore's recent quarterly earnings report showed strong top and bottom line beats, with analyst Ebrahim Poonawala noting that the firm's exposure to large-cap M&A and growth in non-M&A advisory revenues will support EPS growth, making it a compelling investment opportunity.
- Live Nation Growth Potential: Live Nation is viewed as a leader in global live entertainment, with analyst Peter Henderson highlighting robust demand and healthy consumer spending trends that will underpin its medium to long-term growth; despite regulatory pressures, the stock remains attractive, having risen 16% in the past month.
- Medline Market Leader: Analyst Andrew Obin initiated coverage of Medline with a buy rating, forecasting sustainable high-single digit organic growth driven by market share gains in the $175 billion U.S. market, with the stock up 13% over the past month.
- Waystar Steady Growth: Waystar is well-positioned for steady growth supported by stable end-market demand for revenue cycle management solutions, with analysts believing the company can expand relationships with 18 of the top 22 hospitals, driving further growth opportunities.
See More
- Leading Client Satisfaction: An independent survey by Black Book reveals that Waystar ranks first in client satisfaction within the healthcare revenue cycle management industry, outperforming 49 competitors and demonstrating exceptional performance in AI execution and outcomes.
- Significant AI Capabilities: In less than a year, Waystar AltitudeAI has prevented $15 billion in denials and accelerated appeal package generation by 90%, significantly enhancing operational efficiency by reducing processing time from days to minutes.
- Efficient Claims Processing: The Waystar platform achieves approximately 99% clean claim and first-pass acceptance rates, which not only speeds up reimbursement but also enhances accuracy, further solidifying its leadership position in the healthcare payment sector.
- Extensive Client Base: Waystar serves over 30,000 clients, representing more than 1 million providers, including 16 of the institutions on the U.S. News Best Hospitals list, showcasing its broad influence and market penetration in the healthcare industry.
See More
- Leading Client Satisfaction: Waystar achieved a composite score of 9.75 in the Black Book survey, significantly surpassing the second-place score of 8.27, with nearly 100% of surveyed leaders indicating a strong likelihood to renew, highlighting the sustained value and loyalty of its AI platform.
- Exceptional AI Execution: Waystar received the highest score of 9.56 for AI execution, covering critical metrics such as time-to-value, workflow quality, and ROI clarity, underscoring its leadership position in the industry.
- Superior Client Outcomes: Waystar exceeded all benchmarks for client-reported AI operations outcomes, achieving a KPI score of 9.56, reflecting strong performance in denial prevention and workflow automation, which drives faster reimbursement processes.
- Significant Operational Impact: In less than a year, Waystar AltitudeAI has prevented $15 billion in denials and accelerated appeal package generation by 90%, enhancing operational efficiency and ensuring a 99% clean claim rate.
See More








